Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: DIASORIN MOLECULAR, LLC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2022-10-01 to 2025-09-30
Current total value of award: $111720
Description: THE PURPOSE FOR THIS MODIFICATION IS TO DE-OBLIGATE EXCESS FY23 FUNDS, IN ORDER TO REFLECT ACTUAL AMOUNTS USED DURING PERFORMANCE OF THE CONTRACT IN FY23 (01 OCTOBER 2022 - 30 SEPTEMBER 2023).